
Procaps Group Investor Relations Material
Latest events

Investor Update
Procaps Group
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Procaps Group S.A.
Access all reports
Procaps Group S.A. is a healthcare and pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical solutions globally. The company's product offerings include branded prescription drugs across various therapeutic areas, over-the-counter (OTC) consumer healthcare products, and high-potency clinical compounds. Additionally, Procaps provides contract drug development and manufacturing services, specializing in soft gelatin capsule technologies. The company's operations are organized into several units, such as Diabetrics, which focuses on diabetes solutions, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties, each catering to specific healthcare needs. The company is headquartered in Luxembourg, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
PROCF
Country
🇺🇸 United States